JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection

Autor: Zoulim, Fabien, Lenz, Oliver, Vandenbossche, Joris J., Talloen, Willem, Verbinnen, Thierry, Moscalu, Iurie, Streinu-Cercel, Adrian, Bourgeois, Stefan, Buti, Maria, Crespo, Javier, Manuel Pascasio, Juan, Sarrazin, Christoph, Vanwolleghem, Thomas, Shukla, Umesh, Fry, John, Yogaratnam, Jeysen Z.
Zdroj: In Gastroenterology August 2020 159(2):521-533
Databáze: ScienceDirect